News and Trends 28 Sep 2022
Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of its CRISPR genome editing technologies.…